Form 4: Leidos Holdings Director Acquires Stock Options
Insider Transaction Filing
Leidos Holdings Director Noel B. Geer acquired stock options and common stock, increasing his beneficial ownership.
Summary
- Noel B. Geer, a Director at Leidos Holdings, Inc., reported a transaction on May 8, 2026.
- Geer acquired 1,281 stock options with an exercise price of $131.26.
- He also acquired 1,067 shares of common stock.
- Following these transactions, Geer beneficially owns 44,273.8435 shares of common stock directly.
- Additional shares are held indirectly through his spouse and a family trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine disclosure of insider stock option and share acquisition without immediate implications for the company's financial performance or strategic direction.
Positives
- Director Noel B. Geer has increased his direct beneficial ownership of Leidos Holdings, Inc. stock through the acquisition of common stock.
- The acquisition of stock options indicates a potential for future equity participation and alignment with company performance.
Future Outlook
The filing indicates the acquisition of stock options, which suggests a forward-looking perspective on the company's performance, as these options have an exercise price and expiration date.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing details a director's acquisition of equity, which is a common event in the aerospace and defense technology sector where Leidos operates.
Stakeholder Impact
- Shareholders: Increased beneficial ownership by a director may signal confidence in the company's future prospects, though the direct impact on share price is typically minimal for routine option grants and acquisitions.
Next Steps
- The stock options acquired on May 8, 2026, will vest and become exercisable on the earlier of the first anniversary of the grant date or the date of the next annual stockholders' meeting.
- The stock options expire on May 7, 2033.
Key Dates
| Date | Description |
|---|---|
| 05/08/2026 | Earliest transaction date reported and date of stock option acquisition and common stock acquisition. |
| 05/07/2033 | Expiration date of stock options. |
| 05/08/2027 | Date stock options become exercisable (first anniversary of grant date or conclusion of next annual meeting). |
| 05/12/2026 | Date the Form 4 was signed and filed. |
Keywords
Leidos Holdings, LDOS, Form 4, Insider Trading, Stock Options, Beneficial Ownership, Director Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.